Prodopa New Zealand - English - Medsafe (Medicines Safety Authority)

prodopa

viatris limited - methyldopa sesquihydrate 141.5mg equivalent to to 125 mg methyldopa anhydrous - tablet - 125 mg - active: methyldopa sesquihydrate 141.5mg equivalent to to 125 mg methyldopa anhydrous excipient: citric acid   colloidal silicon dioxide disodium edetate dihydrate ethylcellulose guar gum magnesium stearate opadry yellow oy-8462 purified water sodium starch glycolate - hypertension (mild, moderate or severe).

METHYLDOPATE HYDROCHLORIDE injection solution United States - English - NLM (National Library of Medicine)

methyldopate hydrochloride injection solution

american regent, inc. - methyldopate hydrochloride (unii: 7px435dn5a) (methyldopa anhydrous - unii:m4r0h12f6m) - methyldopate hydrochloride 50 mg in 1 ml

METHYLDOPA tablet, film coated United States - English - NLM (National Library of Medicine)

methyldopa tablet, film coated

chartwell rx, llc - methyldopa (unii: 56lh93261y) (methyldopa anhydrous - unii:m4r0h12f6m) - methyldopa is contraindicated in patients: — with active hepatic disease, such as acute hepatitis and active cirrhosis — with liver disorders previously associated with methyldopa therapy ( see warnings ) — with hypersensitivity to any component of these products. — on therapy with monoamine oxidase (mao) inhibitors.

Hydopa 250 mg tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

hydopa 250 mg tablet bottle

alphapharm pty ltd - methyldopa sesquihydrate, quantity: 283 mg (equivalent: methyldopa, qty 250 mg) - tablet, film coated - excipient ingredients: ethylcellulose; disodium edetate; magnesium stearate; guar gum; sodium starch glycollate; colloidal anhydrous silica; citric acid; titanium dioxide; hypromellose; sunset yellow fcf; quinoline yellow; macrogol 400 - indications as at 7 may 1996: hypertension (mild, moderate to severe)